ProCE Banner Activity

Practical Approaches to Managing Key Clinical Issues With Myeloproliferative Neoplasms

Clinical Thought
Read how I approach the most pressing clinical issues in diagnosis and management of polycythemia vera, essential thrombocythemia, and myelofibrosis.

Released: April 09, 2019

Expiration: April 07, 2020

Share

Faculty

Rami S. Komrokji

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Incyte Corporation

Faculty Disclosure

Primary Author

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Rami S. Komrokji, MD, has disclosed that he has received consulting fees from Celgene, Daiichi Sankyo, Inc., Jazz, Novartis, and Pfizer and fees for non-CME/CE services from Jazz and Novartis.